Jayaraman, Swaathi
Hou, Xiaonan
Kuffel, Mary J.
Suman, Vera J.
Hoskin, Tanya L.
Reinicke, Kathryn E.
Monroe, David G.
Kalari, Krishna R.
Tang, Xiaojia
Zeldenrust, Megan A.
Cheng, Jingfei
Bruinsma, Elizabeth S.
Buhrow, Sarah A.
McGovern, Renee M.
Safgren, Stephanie L.
Walden, Chad A.
Carter, Jodi M.
Reid, Joel M.
Ingle, James N.
Ames, Matthew M.
Hawse, John R.
Goetz, Matthew P. http://orcid.org/0000-0002-4383-270X
Funding for this research was provided by:
Mayo Clinic Breast Cancer Specialized Program of Research Excellence Grant (P50CA 116201, P50CA 116201, P50CA 116201, P50CA 116201, P50CA 116201, P50CA 116201)
National Institute of Arthritis and Musculoskeletal and Skin Diseases (RO1 AR068275)
Prospect Creek Foundation
George M. Eisenberg Foundation for Charities
The Regis Foundation
National Institutes of Health (R01 CA133049-01, R01 CA133049-01)
Article History
Received: 2 September 2019
Accepted: 3 May 2020
First Online: 19 May 2020
Ethics approval and consent to participate
: Not applicable.
: All authors agreed on submitting this work for publication.
: MPG reports personal fees from Genomic Health for consulting, others from Novartis, Pfizer, Sermonix, Context Pharm, and Biotheranostics, and grants from Pfizer, Eli-Lilly, outside of the submitted work. The other authors declare that they have no competing interests.